LISATA THERAPEUTICS, INC. — Director's Dealing 2017

Nov 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CALADRIUS BIOSCIENCES, INC. (CLBS)
CIK: 0000320017
Period of Report: 2017-11-01

Reporting Person: LOSORDO DOUGLAS W (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-01	Common Stock	A	49182	—	Acquired	68876	Direct

Footnotes

F1: The shares are restricted. The restricted shares fully vest in three equal installments on the date of grant and on the first and second anniversaries of the date of grant.